✦ LIBER ✦

High-dose chemotherapy and autologous HSCT is feasible for some patients with aggressive NHL

Book ID: 120866943
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200112760-00044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility and toxicity of high-dose ch

Feasibility and toxicity of high-dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast carcinoma

✍ Drakos, P; Nagler, A; Or, R; Naparstek, E; Kapelushnik, J; Slavin, S 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 160 KB

High-dose chemotherapy and autologous bo

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

✍ Robert J. Motzer; Subhash C. Gulati; John P. Crown; Steven Weisen; Maryanne Dohe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 682 KB

Safety and efficacy of high-dose chemoth

Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas

✍ Benjamin Chen; Tauseef Ahmed; Anney Mannancheril; Michael Gruber; Deborah L. Ben 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND Malignant astrocytomas are among the most resistant tumors to curative treatments. Mean survival without treatment is measured in weeks, and even with maximal surgery and radiation, the mean reported survival is < 1 year. The advent of supportive treatments and newer agen

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors

✍ Kazuhiro Tanaka; Tomoya Matsunobu; Akio Sakamoto; Shuichi Matsuda; Yukihide Iwam 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 62 KB

274: Levofloxacine Antibacterial Prophyl

274: Levofloxacine Antibacterial Prophylaxis for Patients Treated with High Dose Chemotherapy and Autologous Stem Cell Transplantation

✍ C.P. Casas; V. Abello; C. Rosales; E. Pedraza; H. Esguerra; A. Linares; M.L. Ros 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Standard chemotherapy is superior to hig

Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis

✍ Jing Wang; Ping Zhan; Jian Ouyang; Bing Chen; Rongfu Zhou; Yonggong Yang 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 219 KB